These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 7025155)
1. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Austrian R Rev Infect Dis; 1981; 3 Suppl():S1-17. PubMed ID: 7025155 [TBL] [Abstract][Full Text] [Related]
2. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. Austrian R J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543 [TBL] [Abstract][Full Text] [Related]
3. Pneumococcal disease and its prevention with polyvalent pneumococcal polysaccharide vaccines--a review. Douglas RM; Riley ID Aust N Z J Med; 1979 Jun; 9(3):327-38. PubMed ID: 37823 [TBL] [Abstract][Full Text] [Related]
4. New vaccines for the prevention of pneumococcal infections. Käyhty H; Eskola J Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245 [TBL] [Abstract][Full Text] [Related]
5. Pneumococcal otitis media and pneumococcal vaccines, a historical perspective. Austrian R Vaccine; 2000 Dec; 19 Suppl 1():S71-7. PubMed ID: 11163467 [TBL] [Abstract][Full Text] [Related]
6. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage. Wright PF; Sell SH; Vaughn WK; Andrews C; McConnell KB; Schiffman G Rev Infect Dis; 1981; 3 Suppl():S108-12. PubMed ID: 7280442 [TBL] [Abstract][Full Text] [Related]
8. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. Swiatlo E; Ware D FEMS Immunol Med Microbiol; 2003 Aug; 38(1):1-7. PubMed ID: 12900048 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. van Dam JE; Fleer A; Snippe H Antonie Van Leeuwenhoek; 1990 Jun; 58(1):1-47. PubMed ID: 2195989 [No Abstract] [Full Text] [Related]
10. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta. Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama. Sloyer JL; Ploussard JH; Howie VM Rev Infect Dis; 1981; 3 Suppl():S119-23. PubMed ID: 7280444 [TBL] [Abstract][Full Text] [Related]
12. Pneumococcal antibodies in patients with chronic obstructive pulmonary disease and their response to pneumococcal capsular polysaccharides: preliminary results. Davis AL; Aranda C; Christianson L; Schiffman G Rev Infect Dis; 1981; 3 Suppl():S183. PubMed ID: 7280447 [No Abstract] [Full Text] [Related]
13. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media. Eskola J Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468 [TBL] [Abstract][Full Text] [Related]
14. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Koskela M Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal vaccine. Rubin LG Pediatr Clin North Am; 2000 Apr; 47(2):269-85, v. PubMed ID: 10761504 [TBL] [Abstract][Full Text] [Related]
16. Pneumococcal infections and the possible need for a vaccine. Kaijser B Scand J Infect Dis; 1979; 11(3):179-84. PubMed ID: 93308 [TBL] [Abstract][Full Text] [Related]
17. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Malley R; Srivastava A; Lipsitch M; Thompson CM; Watkins C; Tzianabos A; Anderson PW Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049 [TBL] [Abstract][Full Text] [Related]